Welcome to LookChem.com Sign In|Join Free
  • or
4(3H)-Quinazolinone, 2-ethyl-3-phenyl-, also known as a quinazolinone derivative, is a chemical compound with the molecular formula C17H14N2O. It belongs to a class of compounds with potential biological and pharmaceutical applications. This specific compound is recognized for its potential as an antitumor and anticancer agent, as well as for its possible antifungal and antibacterial properties. Furthermore, it has shown promise in the development of new treatments for neurological disorders and inflammatory diseases.

5260-41-3

Post Buying Request

5260-41-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5260-41-3 Usage

Uses

Used in Pharmaceutical Industry:
4(3H)-Quinazolinone, 2-ethyl-3-phenylis used as a key intermediate in the synthesis and development of pharmaceutical drugs for its potential as an antitumor and anticancer agent. Its unique structure and properties make it a promising candidate for the creation of new therapeutic agents.
Used in Antifungal and Antibacterial Applications:
4(3H)-Quinazolinone, 2-ethyl-3-phenylis used as an active ingredient in the development of antifungal and antibacterial agents due to its potential to combat various strains of fungi and bacteria, thereby contributing to the treatment of infections.
Used in Neurological Disorders Treatment:
4(3H)-Quinazolinone, 2-ethyl-3-phenylis used as a research compound in the development of new treatments for neurological disorders, leveraging its potential to interact with biological targets relevant to these conditions.
Used in Inflammatory Diseases Treatment:
It is also used as a research compound in the development of treatments for inflammatory diseases, where its properties may help in managing inflammation and related symptoms.

Check Digit Verification of cas no

The CAS Registry Mumber 5260-41-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,6 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5260-41:
(6*5)+(5*2)+(4*6)+(3*0)+(2*4)+(1*1)=73
73 % 10 = 3
So 5260-41-3 is a valid CAS Registry Number.

5260-41-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-ethyl-3-phenylquinazolin-4-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5260-41-3 SDS

5260-41-3Synthetic route

2-aminobenzanilide
4424-17-3

2-aminobenzanilide

Triethyl orthopropionate
115-80-0

Triethyl orthopropionate

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
With acetic acid In ethanol at 110℃; for 24h; Inert atmosphere; Sealed tube;92%
ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

1-phenyl-3-(2-ethoxycarbonylphenyl) carbodiimide
622403-42-3

1-phenyl-3-(2-ethoxycarbonylphenyl) carbodiimide

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
In tetrahydrofuran at -78 - 20℃; for 3h;69%
3-(2,6-dibromophenyl)-2-ethylquinazolin-4(3H)-one

3-(2,6-dibromophenyl)-2-ethylquinazolin-4(3H)-one

A

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

(P)-3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

(P)-3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

Conditions
ConditionsYield
With sodium tetrahydroborate; (R)-DTBM-SEGPHOS; palladium diacetate In N,N-dimethyl-formamide at 0℃; for 21h; Inert atmosphere; enantioselective reaction;A 45%
B 35%
C n/a
2-ethyl-benzo[d][1,3]oxazin-4-one
2916-09-8

2-ethyl-benzo[d][1,3]oxazin-4-one

aniline
62-53-3

aniline

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
With trichlorophosphate In dichloromethane for 4h; Heating;42%
N-propionyl-anthranilic acid anilide
25628-85-7

N-propionyl-anthranilic acid anilide

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
at 250℃;
N-(2-benzoylphenyl)propionamide
549500-24-5

N-(2-benzoylphenyl)propionamide

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
With sodium azide; chloroform; sulfuric acid
aniline
62-53-3

aniline

2-(propionylamino)benzoic acid
19165-26-5

2-(propionylamino)benzoic acid

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
With phosphorus trichloride
With phosphorus trichloride In toluene
With phosphorus trichloride In toluene at 110℃;
anthranilic acid
118-92-3

anthranilic acid

1-chloro-4-methyl-thioxanthone

1-chloro-4-methyl-thioxanthone

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 82 percent / 4 h / Heating
2: 42 percent / phosphorus oxychloride / CH2Cl2 / 4 h / Heating
View Scheme
anthranilic acid
118-92-3

anthranilic acid

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 76 percent / dimethylformamide
2: PCl3 / toluene
View Scheme
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 2 h / 0 °C
2: phosphorus trichloride / toluene / 110 °C
View Scheme
C16H18N2

C16H18N2

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium iodide / ethanol; water / 6 h / 20 °C
2: piperidine / 20 - 50 °C
View Scheme
C20H24N2O2

C20H24N2O2

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
With piperidine at 20 - 50℃; Kornblum decomposition;
N-(2-nitrobenzyl)aniline
33331-19-0

N-(2-nitrobenzyl)aniline

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: platinum(IV) oxide; hydrogen / ethanol / 20 °C
2: ethanol / 5 h / 20 °C
3: potassium iodide / ethanol; water / 6 h / 20 °C
4: piperidine / 20 - 50 °C
View Scheme
N-(2-aminobenzyl)aniline
20887-06-3

N-(2-aminobenzyl)aniline

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: ethanol / 5 h / 20 °C
2: potassium iodide / ethanol; water / 6 h / 20 °C
3: piperidine / 20 - 50 °C
View Scheme
aniline
62-53-3

aniline

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: benzene / 5 h / Reflux; Dean Stark apparatus
1.2: 20 °C
2.1: platinum(IV) oxide; hydrogen / ethanol / 20 °C
3.1: ethanol / 5 h / 20 °C
4.1: potassium iodide / ethanol; water / 6 h / 20 °C
5.1: piperidine / 20 - 50 °C
View Scheme
Multi-step reaction with 2 steps
1.1: thionyl chloride / benzene / 2 h / Inert atmosphere; Reflux
1.2: 4 h / 0 - 20 °C / Inert atmosphere
1.3: 2 h / 85 °C / Inert atmosphere
2.1: acetic acid / ethanol / 24 h / 110 °C / Inert atmosphere; Sealed tube
View Scheme
2-nitro-benzaldehyde
552-89-6

2-nitro-benzaldehyde

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: benzene / 5 h / Reflux; Dean Stark apparatus
1.2: 20 °C
2.1: platinum(IV) oxide; hydrogen / ethanol / 20 °C
3.1: ethanol / 5 h / 20 °C
4.1: potassium iodide / ethanol; water / 6 h / 20 °C
5.1: piperidine / 20 - 50 °C
View Scheme
ethyl 2-(triphenylphosphoranylidene-amino)benzoate
179039-70-4

ethyl 2-(triphenylphosphoranylidene-amino)benzoate

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dichloromethane / 5 h / 0 - 20 °C
2: tetrahydrofuran / 3 h / -78 - 20 °C
View Scheme
2-azidobenzoic acid ethyl ester
90408-05-2

2-azidobenzoic acid ethyl ester

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere
2: dichloromethane / 5 h / 0 - 20 °C
3: tetrahydrofuran / 3 h / -78 - 20 °C
View Scheme
2-aminobenzanilide
4424-17-3

2-aminobenzanilide

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper(I) oxide; tricyclohexylphosphine / chloroform / 24 h / 100 °C / Schlenk technique; Sealed tube
2: 2,3-dicyano-5,6-dichloro-p-benzoquinone / chloroform / 1 h / 20 °C / Schlenk technique; Sealed tube
View Scheme
2-ethyl-3-phenyl-2,3-dihydroquinazolin-4(1H)-one
38511-63-6

2-ethyl-3-phenyl-2,3-dihydroquinazolin-4(1H)-one

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In chloroform at 20℃; for 1h; Schlenk technique; Sealed tube;40.5 mg
2,6-dibromoaniline
608-30-0

2,6-dibromoaniline

2-(propionylamino)benzoic acid
19165-26-5

2-(propionylamino)benzoic acid

A

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

(P)-3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

(P)-3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

3-(2-bromophenyl)-2-ethylquinazolin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: phosphorus trichloride / toluene / 20 h / 80 - 120 °C / Inert atmosphere
2: palladium diacetate; sodium tetrahydroborate; (R)-DTBM-SEGPHOS / N,N-dimethyl-formamide / 21 h / 0 °C / Inert atmosphere
View Scheme
ortho-nitrobenzoic acid
552-16-9

ortho-nitrobenzoic acid

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: thionyl chloride / benzene / 2 h / Inert atmosphere; Reflux
1.2: 4 h / 0 - 20 °C / Inert atmosphere
1.3: 2 h / 85 °C / Inert atmosphere
2.1: acetic acid / ethanol / 24 h / 110 °C / Inert atmosphere; Sealed tube
View Scheme
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

2-(1-bromoethyl)-3-phenylquinazolin-4(3H)-one
860002-83-1

2-(1-bromoethyl)-3-phenylquinazolin-4(3H)-one

Conditions
ConditionsYield
With bromine; sodium acetate; acetic acid at 20℃; for 3h;55%
With bromine; sodium acetate; acetic acid
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

phenylmagnesium bromide

phenylmagnesium bromide

2-ethyl-4,4-diphenyl-4H-benzo[d][1,3]oxazine
50547-57-4

2-ethyl-4,4-diphenyl-4H-benzo[d][1,3]oxazine

2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

2-[1-(2-dimethylamino-ethylamino)-ethyl]-3-phenyl-3H-quinazolin-4-one
860002-89-7

2-[1-(2-dimethylamino-ethylamino)-ethyl]-3-phenyl-3H-quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Br2; AcOH; AcONa
2: ethanol / Heating
View Scheme
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

decanoic acid (2-dimethylamino-ethyl)-[1-(4-oxo-3-phenyl-3,4-dihydro-quinazolin-2-yl)-ethyl]-amide

decanoic acid (2-dimethylamino-ethyl)-[1-(4-oxo-3-phenyl-3,4-dihydro-quinazolin-2-yl)-ethyl]-amide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Br2; AcOH; AcONa
2: ethanol / Heating
3: Et3N / dioxane
View Scheme
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-phenylquinazolin-4(3H)-one

2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-phenylquinazolin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium acetate; acetic acid; bromine / 3 h / 20 °C
2: N,N-dimethyl-formamide / 12 h / 20 °C
3: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 14 h / 100 °C
View Scheme
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

C30H24FN7O2

C30H24FN7O2

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium acetate; acetic acid; bromine / 3 h / 20 °C
2: N,N-dimethyl-formamide / 12 h / 20 °C
3: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 14 h / 100 °C
View Scheme
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

2-(1-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-phenylquinazolin-4(3H)-one

2-(1-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-phenylquinazolin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium acetate; acetic acid; bromine / 3 h / 20 °C
2: N,N-dimethyl-formamide / 12 h / 20 °C
View Scheme
2-ethyl-3-phenyl-3H-quinazolin-4-one
5260-41-3

2-ethyl-3-phenyl-3H-quinazolin-4-one

2-(1-(4-amino-3-(2,3-difluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-phenylquinazolin-4(3H)-one

2-(1-(4-amino-3-(2,3-difluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-phenylquinazolin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium acetate; acetic acid; bromine / 3 h / 20 °C
2: N,N-dimethyl-formamide / 12 h / 20 °C
3: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 14 h / 100 °C
View Scheme

5260-41-3Relevant academic research and scientific papers

Detection of Isotopic Atropisomerism Based on ortho-H/D Discrimination

Saito, Kazuya,Miwa, Shota,Iida, Asumi,Fujimoto, Yuuki,Caytan, Elsa,Roussel, Christian,Kitagawa, Osamu

supporting information, p. 7492 - 7496 (2021/10/02)

Racemic and optically active 3-(2-deuteriophenyl)-2-(1-phenylpropan-2-yl)quinazoline-4-thiones were prepared. The nuclear magnetic resonance spectra clearly show that they exist as a 1:1 mixture of diastereomers due to the isotopic atropisomerism based on ortho-H/D discrimination (N-C axial chirality) and a chiral carbon.

Casein kinase 1[epsilon] inhibitor, pharmaceutical composition and application thereof

-

Paragraph 0207; 0210, (2021/01/11)

The invention discloses a novel substituted pyrazolopyrimidine compound for inhibiting the activity of casein kinase 1[epsilon] (CK1[epsilon]), a stereoisomer or a stereoisomer mixture of the novel substituted pyrazolopyrimidine compound, a pharmaceutically acceptable salt or solvate of the novel substituted pyrazolopyrimidine compound, and application of the compound to preparation of medicine for treating diseases, disorders or symptoms benefiting from the inhibition of the activity of casein kinase 1[epsilon] (CK1[epsilon]). The compound has inhibitory activity on CK1[epsilon] kinase, OCI-LY10 cells and Karpas299 cells, shows good anti-tumor activity in an OCI-LY10 subcutaneous xenogeneic model, shows excellent synergistic anti-tumor activity when being combined with a BTK inhibitor, has good pharmacokinetic properties, and can be applied to treatment of diseases, disorders or symptoms, including cancers, autoimmune diseases and the like, which benefit from inhibition of casein kinase 1[epsilon] activity, alone or in combination with other drugs.

Quinazolin-4(3H)-ones and 5,6-dihydropyrimidin-4(3H)-ones from β-aminoamides and orthoesters

Gavin, Joshua T.,Annor-Gyamfi, Joel K.,Bunce, Richard A.

, (2018/11/24)

Quinazolin-4(3H)-ones have been prepared in one step from 2-aminobenzamides and orthoesters in the presence of acetic acid. Simple 2-aminobenzamides were easily converted to the heterocycles by refluxing in absolute ethanol with 1.5 equivalents of the orthoester and 2 equivalents of acetic acid for 12–24 h. Ring-substituted and hindered 2-aminobenzamides as well as cases incorporating an additional basic nitrogen required pressure tube conditions with 3 equivalents each of the orthoester and acetic acid in ethanol at 110?C for 12–72 h. The reaction was tolerant towards functionality on the benzamide and a range of structures was accessible. Workup involved removal of the solvent under vacuum and either recrystallization from ethanol or trituration with ether-pentane. Several 5,6-dihydropyrimidin-4(3H)-ones were also prepared from 3-amino-2,2-dimethylpropionamide. All products were characterized by melting point, FT-IR, 1H-NMR, 13C-NMR, and HRMS.

Catalytic Enantioselective Synthesis of N-C Axially Chiral Mebroqualone and Its Derivatives through Reductive Asymmetric Desymmetrization

Hirai, Motohiro,Terada, Shumpei,Yoshida, Hiroaki,Ebine, Kenki,Hirata, Tomoaki,Kitagawa, Osamu

, p. 5700 - 5703 (2016/11/17)

In the presence of (R)-DTBM-SEGPHOS-Pd(OAc)2 catalyst, treatment of various 3-(2,6-dibromophenyl)quinazolin-4-ones with NaBH4 gave optically active N-C axially chiral quinazolinone (mebroqualone) derivatives through reductive asymmet

Copper-Catalyzed Tandem Reaction of 2-Aminobenzamides with Tertiary Amines for the Synthesis of Quinazolinone Derivatives

Xu, Wei,Zhu, Xiao-Rui,Qian, Peng-Cheng,Zhang, Xing-Guo,Deng, Chen-Liang

, p. 2851 - 2857 (2016/12/16)

We developed a copper-catalyzed tandem reaction of 2-aminobenzamides with tertiary amines for the formation of quinazolinone derivatives. The strategy includes two steps (cyclization and coupling) performed in one pot. A number of substrates reacted well under standard conditions to give the corresponding quinazolinone derivatives in moderate to good yields.

Functionalized carbodiimide mediated synthesis of 2,3-disubstituted quinazolin-4(3 H)-ones via the tandem strategy of C-nucleophilic addition and intramolecular NH-substitution cyclization

Nakano, Hayato,Kutsumura, Noriki,Saito, Takao

, p. 3179 - 3184 (2012/11/14)

A facile synthesis of quinazolin-4(3H)-ones possessing carbon substituents at positions 2 and 3 has been developed. Key to the synthesis is a tandem strategy involving introduction of a 2-substituent and construction of the quinazolinone framework via C-nucleophilic addition to the carbodiimide cumulenic carbon followed by intramolecular nucleophilic substitution by the newly formed NH moiety at the proximal ester group.

Synthesis of 3h-quinazolin-4-ones and 4h-3,1-benzoxazin-4-ones via benzylic oxidation and oxidative dehydrogenation using potassium iodide-tert-butyl hydroperoxide

Kumar, R. Arun,Maheswari, C. Uma,Ghantasala, Satheesh,Jyothi,Reddy, K. Rajender

, p. 401 - 410 (2011/04/18)

A simple and elegant method for benzylic activation was demonstrated employing the potassium iodide/tert-butyl hydrogen peroxide catalytic system. This methodology was further extended for the synthesis of biologically important heterocycles namely, 3H-quinazolin-4-ones and 4H-3,1-benzoxazin-4-ones including mecloqualone and etaqualone which are important quinazolinone-based drugs used for the treatment of insomnia in good yields.

Synthesis and structure-activity relationships of vasicine analogues as bronchodilatory agents

Mahindroo, Neeraj,Ahmed, Zabeer,Bhagat, Asha,Bedi, Kasturi Lal,Khajuria, Ravi Kant,Kapoor, Vijay Kumar,Dhar, Kanaya Lal

, p. 347 - 368 (2007/10/03)

The series of vasicine (1) analogues, an alkaloid from Adhatoda vasica Nees., were synthesized with changes in A, B or C rings. Compounds 3-19 were evaluated for in vitro bronchodilatory activity using isolated guinea pig tracheal chain. Compounds 3-8 were also synthesized in good yields using microwave-mediated synthesis under solvent free conditions. Compounds 5 and 8 with seven-member C ring were more active than etofylline and caused 100% relaxation of both the histamine and acetylcholine pre-contracted guinea pig tracheal chain. The structure-activity relationship studies showed that the quinazoline and oxo functionalities were essential for activity. The compounds without C ring and instead having aliphatic and phenyl substitutions in B ring showed relaxation against histamine pre-contracted tracheal chain only, 2-methyl substituted analogues, 12 and 13, being most active with 100% relaxation effect. Birkhaeuser Boston 2006.

Synthesis and structure-activity relationship of 3-phenyl-3H-quinazolin-4- one derivatives as CXCR3 chemokine receptor antagonists

Storelli, Stefania,Verdijk, Pauline,Verzijl, Dennis,Timmerman, Henk,Van De Stolpe, Andrea C.,Tensen, Cornelis P.,Smit, Martine J.,De Esch, Iwan J. P.,Leurs, Rob

, p. 2910 - 2913 (2007/10/03)

A series of 3-phenyl-3H-quinazolin-4-ones have been synthesized and tested for affinity and activity at the chemokine CXCR3 receptor. The most potent compound (1d) has been evaluated using radioligand binding and calcium mobilization assays and is considered a useful tool for further characterization of the CXCR3 receptor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5260-41-3